HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study
HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or g...
Gespeichert in:
Veröffentlicht in: | Journal of acquired immune deficiency syndromes (1999) 2003-05, Vol.33 (1), p.82-87 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 87 |
---|---|
container_issue | 1 |
container_start_page | 82 |
container_title | Journal of acquired immune deficiency syndromes (1999) |
container_volume | 33 |
creator | Woody, George E Gallop, Robert Luborsky, Lester Blaine, Jack Frank, Arlene Salloum, Ihsan M Gastfriend, David Crits-Christoph, Paul |
description | HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients. |
doi_str_mv | 10.1097/00126334-200305010-00012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18824018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18824018</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</originalsourceid><addsrcrecordid>eNp1kclOwzAQQC0EoqXwC8gnbgGvTXxEZWmlCiQoXI2TTGggTYoXqv49Li1w4jQe-83YfoMQpuScEpVeEELZkHORMEI4kYSShGz29lCfKiGSNMvEflxLJhNBueyhI-feIjEUQh2iHmWpYlyqPnoZT57xQ-3e8QOUofB11-K6xX4O-M5sMtPgSet87YMHHA-vbHjFl3lwgEddYep2E5vG5J2N_CfgmQXjF9B6_OhDuT5GB5VpHJzs4gA93VzPRuNken87GV1Ok0LwlCUVE5UcymEBihuRZkqKsiqJlEypjFMV_8loCjln3BQpgOQsr5ghFSuYMEbxATrb9l3a7iOA83pRuwLiy1rogtM0y5ggNItgtgUL2zlnodJLWy-MXWtK9Mau_rGrf-3qb7ux9HR3R8gXUP4V7nRGQGyBVdd4sO69CSuweg6m8XP939T4F6qYg6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18824018</pqid></control><display><type>article</type><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><source>Ovid Lippincott Williams and Wilkins Journal Legacy Archive</source><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Free E- Journals</source><creator>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul</creator><creatorcontrib>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul ; Cocaine Psychotherapy Study Group</creatorcontrib><description>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/00126334-200305010-00012</identifier><identifier>PMID: 12792359</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, Inc</publisher><subject>Adolescent ; Adult ; Antisocial Personality Disorder ; Cocaine-Related Disorders - complications ; Cocaine-Related Disorders - therapy ; Continental Population Groups ; Female ; HIV Infections - complications ; HIV Infections - etiology ; HIV Infections - prevention & control ; HIV Infections - transmission ; Humans ; Male ; Middle Aged ; National Institutes of Health (U.S.) ; Patient Dropouts ; Psychotherapy ; Risk Factors ; Risk Reduction Behavior ; Safe Sex ; Sex Factors ; Sexual Behavior ; Treatment Refusal ; United States</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2003-05, Vol.33 (1), p.82-87</ispartof><rights>2003 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</citedby><cites>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-200305010-00012$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00126334-200305010-00012$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12792359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woody, George E</creatorcontrib><creatorcontrib>Gallop, Robert</creatorcontrib><creatorcontrib>Luborsky, Lester</creatorcontrib><creatorcontrib>Blaine, Jack</creatorcontrib><creatorcontrib>Frank, Arlene</creatorcontrib><creatorcontrib>Salloum, Ihsan M</creatorcontrib><creatorcontrib>Gastfriend, David</creatorcontrib><creatorcontrib>Crits-Christoph, Paul</creatorcontrib><creatorcontrib>Cocaine Psychotherapy Study Group</creatorcontrib><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antisocial Personality Disorder</subject><subject>Cocaine-Related Disorders - complications</subject><subject>Cocaine-Related Disorders - therapy</subject><subject>Continental Population Groups</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - etiology</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>National Institutes of Health (U.S.)</subject><subject>Patient Dropouts</subject><subject>Psychotherapy</subject><subject>Risk Factors</subject><subject>Risk Reduction Behavior</subject><subject>Safe Sex</subject><subject>Sex Factors</subject><subject>Sexual Behavior</subject><subject>Treatment Refusal</subject><subject>United States</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kclOwzAQQC0EoqXwC8gnbgGvTXxEZWmlCiQoXI2TTGggTYoXqv49Li1w4jQe-83YfoMQpuScEpVeEELZkHORMEI4kYSShGz29lCfKiGSNMvEflxLJhNBueyhI-feIjEUQh2iHmWpYlyqPnoZT57xQ-3e8QOUofB11-K6xX4O-M5sMtPgSet87YMHHA-vbHjFl3lwgEddYep2E5vG5J2N_CfgmQXjF9B6_OhDuT5GB5VpHJzs4gA93VzPRuNken87GV1Ok0LwlCUVE5UcymEBihuRZkqKsiqJlEypjFMV_8loCjln3BQpgOQsr5ghFSuYMEbxATrb9l3a7iOA83pRuwLiy1rogtM0y5ggNItgtgUL2zlnodJLWy-MXWtK9Mau_rGrf-3qb7ux9HR3R8gXUP4V7nRGQGyBVdd4sO69CSuweg6m8XP939T4F6qYg6Q</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Woody, George E</creator><creator>Gallop, Robert</creator><creator>Luborsky, Lester</creator><creator>Blaine, Jack</creator><creator>Frank, Arlene</creator><creator>Salloum, Ihsan M</creator><creator>Gastfriend, David</creator><creator>Crits-Christoph, Paul</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20030501</creationdate><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><author>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antisocial Personality Disorder</topic><topic>Cocaine-Related Disorders - complications</topic><topic>Cocaine-Related Disorders - therapy</topic><topic>Continental Population Groups</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - etiology</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>National Institutes of Health (U.S.)</topic><topic>Patient Dropouts</topic><topic>Psychotherapy</topic><topic>Risk Factors</topic><topic>Risk Reduction Behavior</topic><topic>Safe Sex</topic><topic>Sex Factors</topic><topic>Sexual Behavior</topic><topic>Treatment Refusal</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woody, George E</creatorcontrib><creatorcontrib>Gallop, Robert</creatorcontrib><creatorcontrib>Luborsky, Lester</creatorcontrib><creatorcontrib>Blaine, Jack</creatorcontrib><creatorcontrib>Frank, Arlene</creatorcontrib><creatorcontrib>Salloum, Ihsan M</creatorcontrib><creatorcontrib>Gastfriend, David</creatorcontrib><creatorcontrib>Crits-Christoph, Paul</creatorcontrib><creatorcontrib>Cocaine Psychotherapy Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woody, George E</au><au>Gallop, Robert</au><au>Luborsky, Lester</au><au>Blaine, Jack</au><au>Frank, Arlene</au><au>Salloum, Ihsan M</au><au>Gastfriend, David</au><au>Crits-Christoph, Paul</au><aucorp>Cocaine Psychotherapy Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>33</volume><issue>1</issue><spage>82</spage><epage>87</epage><pages>82-87</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><abstract>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>12792359</pmid><doi>10.1097/00126334-200305010-00012</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-4135 |
ispartof | Journal of acquired immune deficiency syndromes (1999), 2003-05, Vol.33 (1), p.82-87 |
issn | 1525-4135 1944-7884 |
language | eng |
recordid | cdi_proquest_miscellaneous_18824018 |
source | Ovid Lippincott Williams and Wilkins Journal Legacy Archive; MEDLINE; Journals@Ovid Complete; Free E- Journals |
subjects | Adolescent Adult Antisocial Personality Disorder Cocaine-Related Disorders - complications Cocaine-Related Disorders - therapy Continental Population Groups Female HIV Infections - complications HIV Infections - etiology HIV Infections - prevention & control HIV Infections - transmission Humans Male Middle Aged National Institutes of Health (U.S.) Patient Dropouts Psychotherapy Risk Factors Risk Reduction Behavior Safe Sex Sex Factors Sexual Behavior Treatment Refusal United States |
title | HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T16%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV%20Risk%20Reduction%20in%20the%20National%20Institute%20on%20Drug%20Abuse%20Cocaine%20Collaborative%20Treatment%20Study&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Woody,%20George%20E&rft.aucorp=Cocaine%20Psychotherapy%20Study%20Group&rft.date=2003-05-01&rft.volume=33&rft.issue=1&rft.spage=82&rft.epage=87&rft.pages=82-87&rft.issn=1525-4135&rft.eissn=1944-7884&rft_id=info:doi/10.1097/00126334-200305010-00012&rft_dat=%3Cproquest_cross%3E18824018%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18824018&rft_id=info:pmid/12792359&rfr_iscdi=true |